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Abstract
Mycobacterium (M.) bovis can infect cats and is a demonstrated zoonosis. We describe 
an outbreak of M. bovis in pet cats across England and Scotland associated with feed-
ing a commercial raw food diet. Forty-seven cats presented with (pyo)granulomatous 
lesions, lymphadenopathy, pulmonary and/or alimentary disease over a one-year pe-
riod where M. bovis infection was suspected or definitively diagnosed, and the cats 
all consumed the same specific brand of commercial raw venison pet food. Infection 
with M. bovis genotype 10:a was confirmed by culture and DNA typing of isolates in a 
small number of cases (n = 5); PCR was used in combination with or as an alternative 
to culture (n = 12) and/or infection with a Mycobacterium tuberculosis complex group 
organism was strongly suggested by positive responses to an interferon-gamma re-
lease assay (IGRA; n = 34). Asymptomatic at-risk cats were screened by IGRA, iden-
tifying a further 83 infected cats. The five culture-positive cases were distributed 
across areas of England and Scotland at low risk of endemic bovine tuberculosis. 
Investigations revealed affected cats were mainly indoor-only, and had been fed the 
same commercial raw food as at least part of their diet. This diet was recalled by the 
manufacturer due to failure of statutory meat inspection of the component venison. 
As far as possible, other sources of infection were explored and excluded, including 
wildlife contact, access to raw milk and living with people with active M. bovis infec-
tion. Four owners and one veterinary surgeon were found to have high likelihood of 
latent tuberculosis infection. One owner required treatment. Although it was not 
possible to conclusively demonstrate a zoonotic origin for these infections, neither 
was it possible to eliminate the possibility. Our results provide compelling evidence 
that the commercial raw diet of these cats was the likely route of M. bovis infection 
in this outbreak of cases.
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1  | INTRODUC TION
Mycobacterium (M.) bovis is one of the member species of the 
Mycobacterium tuberculosis complex (MTBC) which are capable of 
causing tuberculosis across a broad taxonomy of species including 
but not limited to humans, cattle, deer, dogs and cats (Allen, 2017; 
Phillips et al., 2003; Sales et al., 2001).
Feline infections with M. bovis are strongly co-localized to 
areas of the UK with a high prevalence of infections in cat-
tle (Gunn-Moore et al., 2011b, 2017), termed the high-risk area 
(HRA) of England by the Department for Environment, Food and 
Rural Affairs (Defra) and “high TB areas of Wales” by the Welsh 
Government, 2014. Conversely, feline M. bovis infections are very 
rare in Scotland and the low-risk area (LRA) of England, and have 
somewhat higher incidence in the edge area located between the 
LRA and HRA of England as evidenced by a M. bovis cluster in cats 
in Berkshire in 2013 (Roberts et al., 2014).
Within the MTBC group of pathogens, M. bovis has the broadest 
host range and poses a substantial zoonotic risk (Biet et al., 2005; Sales 
et al., 2001; Suzuki et al., 2010). Disease in humans due to infection 
with M. bovis, termed “zoonotic tuberculosis” by the World Health 
Organisation (WHO), is a major global public health priority in devel-
oping countries which resulted in nearly 150,000 cases and at least 
12,500 deaths worldwide in 2010 (World Health Organisation, 2017). 
Approximately a third of feline mycobacteriosis cases in the UK are 
caused by MTBC pathogens; in the only published study, M. microti was 
cultured from 19% of all submitted cases of feline mycobacteriosis, and 
15% were caused by M. bovis (Gunn-Moore et al., 2011a).
Characterisation of the typical clinical manifestations of feline 
mycobacterial diseases in the UK has shown that 74% of cases pres-
ent with single or multiple cutaneous lesions, 47% with lymphade-
nopathy (typically submandibular or popliteal) and 10%–16% with 
pulmonary or systemic signs (Gunn-Moore et al., 2011a). The remain-
der of cases are small numbers of relatively rare presentations such 
as alimentary, joint or ocular mycobacteriosis (Gunn-Moore, 2014; 
Clarke et al., 2017; Stavinohova, et al., 2019).
We have previously reported on a highly unusual group of 13 
confirmed or highly likely M. bovis tuberculosis cases in pet cats 
(O’Halloran, Gunn-Moore, et al., 2018; O’Halloran et al., 2019). 
Initially, a striking feature was that several of these cases presented 
with one of the rarest manifestations of disease, alimentary tubercu-
losis. The investigation became more complex when diagnostic tests 
indicated M. bovis infections, as nearly all of these cats were living in 
areas of the UK which have either a very low prevalence of M. bovis 
in cattle and badger (such as the North East of England), or Scotland, 
which holds officially M. bovis free status (for cattle) (APHA, 2017; 
O’Halloran et al., 2019). Suspicions were raised with regard to a pos-
sible link to diet as all cats were indoor-only, had no access to alter-
native sources of infection as far as we could determine, and they 
were all fed the same commercial raw food product, as either all or 
part of their diet (Food Standards Agency, 2018; O’Halloran et al., 
2019).
We concluded that these initial findings provided circumstan-
tial evidence of an association between the commercial raw diet of 
these cats and their M. bovis infections. Since then, further cases 
have been diagnosed and an epidemiological investigation under-
taken; the purpose of this publication is to outline in full our find-
ings, and conclusions from both the clinical and epidemiological 
investigations.
2  | CLINIC AL INVESTIGATIONS
2.1 | Case definition
For cases to be included in this study, feline M. bovis infection was 
either strongly suspected based on clinical presentation and owner-
reported history, combined with a positive interferon-gamma re-
lease assay or definitively diagnosed by tissue culture or PCR, and 
the cat(s) had to have consumed the same raw commercial pet food 
as part or all of their diet.
2.2 | Clinical presentation of cases
Forty-seven cats from 43 households (Table 1) have been diagnosed 
with active tuberculous disease linked to this outbreak at the time 
of writing. All 47 cases were presented to their general practice 
veterinary surgeons over the course of one year (July 2018 to July 
2019). The majority of affected cats (36/47, 76.6%) were pedigree 
breeds including ten Persians, eight Bengals, five Maine Coons, four 
British Shorthairs, two Ragdolls and one each of Siamese, Oriental, 
Abyssinian, Burmese, Toyger, British Blue and one Bengal cross cat. 
The remaining nine cats were non-pedigrees: eight domestic short-
hairs and one domestic longhair. Cases were distributed across 
England and mainland Scotland (Figure 1).
The age at presentation ranged from three-month-old kittens 
to 13-year-old adults, with a median age of two years. There was 
no statistical difference between the number of male or female cats 
presenting with disease (X2
1
 = 1.48, p > .05); approximately half of 
the cats (24/47, 51.0%) were neutered males and ten cats were neu-
tered females (21.3%), whilst nine were entire females (19.1%) and 
four (8.5%) were entire males.
The clinical signs noted were most frequently non-specific signs 
of ill health, including combinations of lethargy (18/47 cats, 38.3%), 
hyporexia and poor or declining body weight/condition (15/47 cats, 
31.9%).
K E Y W O R D S
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TA B L E  1   Details of the active cases of tuberculosis in the cats affected in this outbreak
Case No.
Location 
(county) Datea  Breed Age Sex
Positive 
mycobacterial tests
Clinical sign(s) noted by the 
owner(s)
1 Durham July 2018 Siamese 2 years MN IGRA Lethargy, hyporexia and 
pyrexia
2 Durham Aug 2018 Oriental 2 years FN IGRA Chronic cough
3 Brighton Aug 2018 DSH 1 year FN PCR and IGRA Lethargy, hyporexia and 
weight loss
4 Norfolk Sept 2018 DLH 1.5 years MN PCR and IGRA Diarrhoea
5 Devon Oct 2018 Bengal cross 6 years FN Culture and PCR Lethargy and hyporexia
6 Devon Oct 2018 Abyssinian 4 years MN IGRA Lethargy and hyporexia
7 Essex Oct 2018 Maine Coon 1.5 years MN IGRA Pyrexia and 
lymphadenomegaly
8 Norfolk Nov 2018 Burmese 1.5 years MN PCR Hyporexia and pyrexia
9 Surrey Nov 2018 British Shorthair 4 months FE IGRA Respiratory distress
10 Dumfries Dec 2018 Bengal 5 years FN Culture and IGRA Respiratory distress
11 Dumfries Dec 2018 Bengal 5 years FN IGRA Weight loss
12 Durham Jan 2019 Toyger 2 years MN IGRA Blindness
13 Aberdeenshire Feb 2019 Ragdoll 10 months MN Culture and IGRA Respiratory distress
14 Hertfordshire Feb 2019 DSH 2 years FN IGRA Chronic cough
15 Hertfordshire Feb 2019 DSH 6 years MN IGRA Weight loss
16 Manchester Feb 2019 Persian 1 year MN IGRA Respiratory distress
17 Manchester March 2019 Persian 1 year MN IGRA Chronic cough
18 Manchester March 2019 Persian 10 months MN IGRA Diarrhoea
19 Manchester March 2019 Persian 1 year FE IGRA Diarrhoea
20 Manchester March 2019 Persian 1.5 years FN IGRA Vomiting and diarrhoea
21 Manchester March 2019 Ragdoll 9 year MN IGRA Weight loss
22 Cheshire March 2019 Persian 1 year FE IGRA Mild respiratory disease 
noted by veterinarianb 
23 Glasgow March 2019 DSH 1.5 years MN Culture Chronic purulent skin lesion
24 Glasgow March 2019 DSH 1.5 years MN IGRA Sub-clinical lung diseasec 
25 Cheshire March 2019 DSH 2 years FN PCR Ulcerated skin mass
26 Dumfries April 2019 Maine Coon 3 years ME PCR and IGRA Weight loss and pyrexia
27 Cheshire April 2019 Persian 1 year FN IGRA Subclinical lung diseasec 
28 Lancashire April 2019 British Shorthair 1 year MN IGRA Weight loss
29 Merseyside April 2019 Persian 1 year MN PCR Lethargy and 
lymphadenomegaly
30 Surrey April 2019 British Blue 3 year FE Culture and IGRA Lethargy, pyrexia and 
weight loss
31 Aberdeenshire April 2019 Bengal 4 years FN PCR and IGRA Mild respiratory disease 
noted by veterinarianb 
32 Cardiff April 2019 Bengal 2 years MN IGRA Abdominal mass
33 Devon April 2019 Maine Coon 6 months MN IGRA Mild respiratory disease 
noted by veterinarianb 
34 Glasgow April 2019 British Shorthair 3 year MN IGRA Haemoptysis
35 Suffolk April 2019 Bengal 5 years FE PCR and IGRA Lethargy, hyporexia and 
pyrexia
36 Suffolk May 2019 Sphinx 5 years FE IGRA Abdominal mass
37 Hampshire May 2019 Maine Coon 3 years ME IGRA Ascites
(Continues)
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The clinical abnormality most frequently reported by the ex-
amining veterinary surgeons was “respiratory signs”, which was 
recorded in 72.3% (34/47) of cases. The severity of these signs 
ranged from mild increases in respiratory rate and/or effort, 
through to a persistent cough and pneumonia, causing life-threat-
ening dyspnoea; it was the recorded reason for euthanasia in two 
cases (Figure 2a,b). In a further three cases (6.4%), thoracic lymph-
adenomegaly of the peribronchial, sternal and/or mediastinal 
lymph nodes was the only gross lesion detected on investigation 
of the primary presenting complaint (lethargy in two cats and hy-
porexia in one cat).
Abdominal masses (which were confirmed to be granulomas 
following further testing) were palpable in 23 of the 47 cats 
(48.9%), whilst the abdominal viscera (excluding lymph nodes) were 
found to be structurally abnormal (either enlarged and/or contain-
ing granulomatous lesions, Figure 3) in a further four cases (8.2%) 
as visualized by abdominal radiography, ultrasonography and/or 
computed tomography (Figure 4). The abdominal lymph nodes as-
sociated with the alimentary system (Figure 5) were enlarged in 
four cats (8.2%) and enlarged as part of a generalized lymphade-
nomegaly in a further eight cats; hence, 12 cases (25.5%) had ab-
dominal lymphadenomegaly. All cats had a minimum of abdominal 
radiography, so while significant organomegaly should have been 
detected, lymphadenomegaly may have been missed in those cats 
that did not have concurrent abdominal ultrasonography. Overall, 
ante mortem diagnostic imaging of the alimentary tract and asso-
ciated structures were found to contain gross pathology in 31 of 
the 47 cases (66.0%), but clinical signs directly relatable to the gas-
trointestinal system (vomiting, diarrhoea or constipation) were the 
main presenting sign in only six cats (12.8%).
Uncommon clinical signs included non-healing skin lesions 
(Figure 6) in four cats (8.2%), orthopaedic involvement in two cats 
(4.1%) and optic disease (Figure 7) in two cats (4.1%).
At clinical examination pyrexia was noted in 17 cats (36.2%); 
where recorded, the temperature ranged from 39.8°C to 41.1°C, 
with a median of 40.0°C (reference interval: 37.7–39.1°C). Routine 
haematological evaluation was conducted in all of the 47 cats and 
revealed a non-regenerative anaemia in ten cats (21.3%) and a 
mild-to-moderate mature neutrophilia in six cats (12.8%). Serum bio-
chemistry was also assessed in all 47 actively infected cats and was 
largely unremarkable; only two cats (4.1%) showed increased liver 
enzyme activity, affecting both alanine aminotransferase and alka-
line phosphatase. One of these cats had a large hepatic granuloma 
extending into the biliary duct, whilst the cause of these increases 
was not identified in the second cat.
In the 12 cats that were tested for feline leukaemia virus (FeLV) 
antigen and anti-feline immunodeficiency virus (FIV) antibodies, all 
cats were found to be negative.
2.3 | Mycobacterial testing
Specialist mycobacterial culture and subsequent genotyping at a 
national reference laboratory (Animal and Plant Health Agency 
[APHA], Weybridge in the UK) using the approved standardized 
protocol remain the only test that can result in official confirmation 
of M. bovis infection of companion animals in the UK (Kamerbeek 
et al., 1997; Middlemiss & Clark, 2018). The APHA protocol for 
genetic identification of strains is the same used for bovine tuber-
culosis in cattle in the UK, comprised of spoligotyping according 
Case No.
Location 
(county) Datea  Breed Age Sex
Positive 
mycobacterial tests
Clinical sign(s) noted by the 
owner(s)
38 Herefordshire May 2019 DSH 2 years FE PCR Mild respiratory disease 
noted by veterinarianb 
39 Suffolk May 2019 DSH 2 years ME IGRA Weight loss
40 Suffolk May 2019 Persian 9 months FE IGRA Lethargy and hyporexia
41 Cumbria May 2019 Persian 9 months FE IGRA Lethargy, hyporexia and 
pyrexia
42 Oxfordshire June 2019 Bengal 1 year MN PCR Lymphadenomegaly
43 Yorkshire June 2019 Maine Coon 1.5 years ME IGRA Chronic cough
44 Lincolnshire June 2019 Bengal 1.5 years MN IGRA Ulcerated skin mass
45 Lincolnshire June 2019 Bengal 1.5 years MN IGRA Ulcerated skin mass
46 Surrey July 201 DSH 2 years MN Culture Weight loss and lethargy
47 Cambridgeshire July 2019 DSH 1.5 years FN Culture Weight loss and lameness
aDate is defined as the month the patient was presented to its general practitioner veterinarian with clinical signs of, or owner concerns regarding, 
possible tuberculosis. 
bFour cats showed mild clinical signs that were not initially observed by the owners but were noted on clinical examination by the attending 
veterinary surgeon. 
cTwo cats showed no active clinical signs of disease but did have structural disease consistent with possible mycobacterial infection noted on 
radiographs. 
TA B L E  1   (Continued)
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F I G U R E  1   A map of the UK showing the distribution of 45 active clinical cases and 2 inactive clinical cases of M. bovis infection in 
domestic cats associated with the consumption of a specific raw food diet
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to the variable number of tandem repeat (VNTR) results and sub-
sequent mycobacterial interspersed repeat units as established by 
Kamerbeek et al. (1997), updated by Smith and Upton (2011) and 
widely utilized and described elsewhere (Frothingham and Meeker-
O’Connell, 1998; Roring et al., 2002; Skuce et al., 2002).
From this outbreak, grossly diseased tissue samples from eleven 
cats were obtained at post-mortem examination and submitted for 
mycobacterial culture at APHA Weybridge. All post-mortem exam-
inations were conducted either at APHA veterinary investigation 
centres by APHA pathologists or at the Roslin Institute, University 
of Edinburgh, under Containment Level 3 conditions by the authors 
(COH/JH). Five of the eleven cultures (45.5%) resulted in positive 
results, and genotype analysis has identified all five isolates as gen-
otype 10:a. The five cats were resident across the UK in households 
located in Scotland and the LRA of England.
Remaining food samples were requested from owners of af-
fected cats, and five were sent to the team at the Roslin Institute, 
Edinburgh. Culture of viable M. bovis was attempted as previously 
described (O’Halloran et al., 2019); briefly, inside a Containment 
Level 3 (CL3) laboratory up to 20 g of tissue was homogenized, 
decontaminated with 5% oxalic acid or 10% sodium hydroxide, 
and centrifuged, and the pellet was resuspended in sterile phos-
phate-buffered saline (PBS) and centrifuged again. The homogenate 
was then resuspended in PBS and sown onto solid Middlebrook 
7H11 OADC (Sigma, UK) and liquid Middlebrook 7H9 ADC (Sigma, 
UK) culture media. Cultures were read at 6 weeks of incubation 
and again at 14 weeks in order to allow sufficient time required for 
slow-growing mycobacteria MTBC to produce colonies if viable M. 
bovis was present in the tissue sample.
Although it is the reference standard test, mycobacterial culture 
does have a number of limitations. For example, as a prerequisite it 
requires the acquisition and submission of fresh or frozen biopsy sam-
ples; however, given the location of many of the lesions inside body 
cavities (i.e., the chest and abdomen) this made retrieving enough 
sample for culture ante mortem an invasive procedure that many of 
these cases were not clinically fit to undergo. For most of these cats, 
it was only possible to obtain very small samples by needle aspiration 
for cytological examination. In a number of cases where larger biop-
sies had been obtained, they had been formalin-fixed and submitted 
for histopathological examination and as such were unavailable for 
culture. For all of the fixed samples, we utilized molecular testing 
methods (GenoType MTBC; Hain Lifescience GmbH, Germany) at 
Leeds University Teaching Hospital. This molecular methodology is 
used as standard of care in the diagnosis of human tuberculosis in 
the UK, and although not specifically validated for companion animal 
(tissue) samples, this assay is able to diagnose human mycobacte-
rial infections with MTBC organisms; specific gene probes are then 
used to determine the infecting species within this group, including 
the identification of M. bovis (National Institute for Health & Care 
Excellence, 2016). Twelve of the 15 cat samples tested generated 
positive PCR test results for the presence of mycobacterial DNA; 
further analysis revealed one infection with an MTBC organism (but 
there was insufficient DNA for narrower speciation), and 11 were 
identified to the species level as M. bovis infections. Two of the M. 
F I G U R E  2   (a) A latero-lateral thoracic radiograph of an affected cat (a four-year-old female neutered indoor-only Bengal cat) showing 
two cavitating lesions within the lower respiratory tract. The cat deteriorated clinically and was euthanized on welfare grounds. (b): Post-
mortem examination of the same cat revealed extensive fibrinopurulent exudate in the thoracic cavity and the extent of the granulomatous 
lesions. Lung samples submitted for mycobacterial culture were positive for M. bovis 10:a
(a) (b)
F I G U R E  3   The spleen of an 18-month-old male neutered 
Burmese cat at laparotomy showing multifocal raised white-
pink circular lesions later confirmed as granulomatous on 
histopathology; they contained acid-fast bacilli with mycobacterial 
morphology. The liver of this cat was similarly affected
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bovis-positive test results were subsequently confirmed by myco-
bacterial culture of contemporaneously obtained visibly lesioned 
tissue samples.
The cat identified by PCR as being infected with an MTBC or-
ganism but with insufficient DNA for speciation was included in this 
outbreak investigation even though further molecular testing was 
not possible. This cat was an 18-month-old indoor-only domestic 
shorthair which had been fed exclusively on the implicated diet 
since its acquisition by the owners at eight weeks of age, it had a 
contemporaneous interferon-gamma release assay (IGRA) result 
strongly suggestive of M. bovis infection, as well as lymph node aspi-
rate cytology which confirmed the presence of acid-fast bacilli with 
mycobacterial morphology. Cumulatively, these findings were taken 
to support its inclusion as an affected cat.
Immunodiagnostic assays for the diagnosis of tuberculosis are 
used globally to test human and bovine populations (McCormick-Baw 
et al., 2018; Wood & Jones, 2001). The most successful of these to 
date is the IGRA; first developed to aid in the eradication of M. bovis 
from cattle populations in Australia, the assay detects antigen-specific 
T-cell responses to mycobacterial antigens from circulating leucocytes 
F I G U R E  4   Ultrasound examination of an 18-month-old male 
neutered indoor-only Maine Coon cat showing an approximately 
2 × 2.5 cm mass in the abdominal cavity
F I G U R E  5   A markedly enlarged mesenteric lymph node from 
the same cat as Figure 4 seen during the laparotomy
F I G U R E  6   The non-healing skin wound over the left pelvis of 
a two-year-old male, indoor-only, neutered domestic shorthair cat 
that was subsequently culture-positive for M. bovis 10:a
F I G U R E  7   Ocular examination of a two-year-old indoor-only 
female neutered British Shorthair cat presented for conjunctival 
hyperaemia revealed a highly vascular mass over the optic nerve, 
later diagnosed (following enucleation) as granulomatous chorio-
retinitis with acid-fast bacilli, plus associated retinal detachment
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to diagnose infection (Rothel et al., 1992; Wood & Jones, 2001). This 
first test, the BOVIGAM® assay, is now widely used to detect the 
cell-mediated immune response to M. bovis in cattle, sheep, goats, 
buffalo and bison (Anusz et al., 2017; Pesciaroli et al., 2014; Wood & 
Jones, 2001). With small adaptations, the test protocol has proved to 
be extremely useful in humans, and the WHO’s new 2018 guidelines 
on the management of human tuberculosis now support the global use 
of IGRA testing at-risk populations (Chee et al., 2018; McCormick-Baw 
et al., 2018). In 2008, adaptations to the test procedure were under-
taken by the TB Research Group at the then Veterinary Laboratories 
Agency (now APHA), to optimize the test for domestic cats (Rhodes 
et al., 2008a). The resultant feline IGRA is now commercially available 
via Biobest Laboratories, Edinburgh, UK, and although the number 
of tested cats remains too small to allow official validation to World 
Organisation for Animal Health (OIE) standards, several publications 
have indicated that this is a useful test to generate rapid information on 
the infection status of cats (Gunn-Moore, 2014; Rhodes et al., 2008b; 
Rhodes et al., 2011). The methodology and interpretation of this test 
have been previously published, and the same protocol was used to 
test cats involved in this outbreak (O’Halloran et al., 2019; Rhodes 
et al., 2008a). Of particular relevance to this investigation is that this 
test is currently the cheapest option available to owners. The combina-
tion of lack of invasiveness, speed of generating results and lower cost 
may explain the high number of IGRA tests in this instance rather than 
the validated reference standard culture.
In a previous M. bovis outbreak, we utilized an IGRA for screening 
apparently healthy kennel-housed Foxhounds with a similar test pro-
tocol to the feline IGRA (O’Halloran, Hope et al., 2018). We considered 
that a positive interferon-gamma response to purified protein derived 
(PPD) from M. bovis (PPDB) was indicative of a significant antigen-spe-
cific T-cell response to MTBC bacteria. Such a response was thought 
to be suggestive of significant challenge and probable infection, rather 
than just exposure to these mycobacteria. We applied the same criteria 
to the cats in this outbreak and advised that the 83 IGRA-positive but 
apparently clinically healthy cats should be further evaluated for the 
presence of lesions by full clinical examination and diagnostic imag-
ing. As was the case for the Foxhounds, none of these cats showed a 
significant response to PPD from M. avium. The IGRA responses were 
deemed to be indicative of M. bovis infection in cats where there was 
a response to the peptide cocktail of ESAT-6/CFP-10 as well as PPDB.
During this outbreak, 44 of the 47 clinical cases were tested by 
IGRA, of which 40 (90.9%) tested positive by the above definition. 
Of these, eight cases were supported or confirmed by either PCR 
test (five cats) or subsequent positive cultures (three cats).
2.4 | Sub-clinical and latent cases
As the outbreak continued and the commercial raw diet was impli-
cated, owners who fed their cats the diet became concerned that their 
cats could be infected. In addition, some of the affected cats lived 
with other cats, so owners were worried that their other cats could 
be at risk. Since the IGRA is the only available test for mycobacterial 
infection that can be performed on an animal with no visible lesions, 
many of these owners chose to have their cats tested using this assay. 
At the point of writing, 143 at-risk clinically well cats that had con-
sumed the implicated food had been tested by IGRA, of which 83 
(58.0%) gave positive results suggestive of MTBC infections.
Six of the cats (7.2%) were found to have lesions compatible with 
tuberculosis, as imaging revealed mild interstitial pulmonary disease 
and associated lymphadenomegaly that were not causing clinical 
signs as noted by the owners; however, four of the six cats had mild 
respiratory changes detected by the attending veterinary surgeon 
(i.e., were active clinical cases); this testing allowed these cats to 
be treated at an early/mild stage of infection. The additional two 
cats with no clinical signs (Table 1) but due to the presence of struc-
tural disease were designated as active clinical cases and were both 
treated medically due to the pathology identified.
The remaining 77 cats were IGRA-positive to at least PPDB with 
no detectable disease. These cats were deemed likely to be sub-clin-
ically or latently infected, and owners were advised that they should 
be closely monitored for the onset of clinical signs and/or prophylac-
tic therapy could be instigated at their discretion.
2.5 | Public health considerations
The incidence of culture-confirmed zoonotic transmission of M. 
bovis from cats is very rare with only six cases reported in the litera-
ture (Isaac, et al., 1983; Lewis-Jonsson, 1946; Roberts et al., 2014; 
Une & Mori, 2007). However, there may be particular risk to owners 
who have compromised immune function such as those receiving 
chemotherapy, radiotherapy or TNF inhibitors (Hofland, et al., 2013; 
Simonsen, et al., 2017). Therefore, owners of cats with active dis-
ease should be advised to seek medical advice if they are at elevated 
risk and/or if cats have lesions that are discharging (purulent) mate-
rial or if they have a productive cough.
Owner screening tests (QuantiFERON GoldTM IGRA and/or tu-
berculin skin tests) conducted to date have identified latent tubercu-
losis infections (LTBI) in four owners and one vet from seven people 
tested to the author’s knowledge. All of these people had been 
exposed to severe feline cases with purulent lesions; however, it is 
unclear whether this represents zoonotic transmission from these 
cats, infection from handling suspect contaminated food, or whether 
these individuals were infected at an earlier time with any member 
of the MTBC (not necessarily M. bovis). Public health agencies in the 
UK have previously assessed the risk to immunocompetent owners 
from M. bovis-infected pets and have concluded that there is “very 
low” risk of zoonotic transmission (Public Health England, 2014).
3  | EPIDEMIOLOGIC AL INVESTIGATION
The only common factor linking these cases was found to be the 
specific brand of commercial raw cat food consumed by the cats, 
Natural Instinct Wild Venison, and being mostly indoor cats.
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Two breeding colonies were affected; one in the north of England 
had three clinical cases, plus four clinically well cats (two that were 
IGRA-positive and two IGRA-negative) in the colony. Tracing re-
homed kittens identified ten with severe clinical signs and two that 
were IGRA-positive but clinically well. The second breeder, located 
in the south of Scotland, had eight breeding cats of which one was 
clinically sick (IGRA-positive, culture-negative) and four were clini-
cally well but IGRA-positive. Ten kittens from two litters rehomed 
from the second breeder were traced; half of these were tested by 
IGRA, and all five were negative. There were no other common as-
sociations between the remaining cats.
With mycobacterial infections, the route of exposure typically 
leads to infection of the local structures and so disease (usually) 
presents with clinical signs related to that region. Diagnostic im-
aging (radiography and/or ultrasonography) of the alimentary tract 
and associated lymphoid structures were found to contain lesions in 
31 of the 47 cases (66.0%) which are consistent with challenge via 
the gastrointestinal route, supporting the hypothesis of food as the 
common source of infection. Five cats presented with large lung ab-
scesses, which could be associated with spread via the retropharyn-
geal lymph nodes having become infected when eating, aspiration 
of small contaminated food particles whilst eating or may represent 
dissemination of disease.
All cases were presented to their general practice veterinary sur-
geons between July 2018 and July 2019. An estimate of the latent 
period for alimentary infections with tuberculosis in cats is two to 
five months based on experimental data from the 1900s presented 
by Francis (1958) in which very large doses (1-10 mg) of M. bovis ba-
cilli were given by mouth and produced lesions 40 to 121 days later. 
Beyond this, the kinetics of feline M. bovis infection following oral 
challenge are unknown. It is likely that in at least some cats, a long 
sub-clinical/latent phase is seen, as in cattle and humans, and this 
may extend the upper range of time from infection to disease occur-
ring to many months or even years.
Identifying a likely infection window and determining whether 
the cats were all infected by one particular batch of contaminated 
food are difficult questions to answer. The earliest clinical signs were 
reported in the first weeks of July 2018; if a minimum pre-clinical 
period is approximately two months, then a contaminated batch of 
raw pet food manufactured in early May 2018 would be implicated. 
With the apparent last cases being identified in July 2019, this theo-
retically includes all batches of food made as late as December 2018 
when this product was recalled and production of this product was 
ceased by the company. With the possibility of long sub-clinical/
latent infections adding a considerable degree of open-endedness 
to the period following infection before signs appear, contaminated 
batches could theoretically have been produced during the whole of 
2018, or even earlier.
An important factor that potentially explains the extended period 
of this cluster is long storage of the pet food in home freezers. Since 
the commercial raw diet was marketed with “Limited Availability”, 
owners reported that they tended to bulk purchase when it was 
available. The freezer shelf life was several months (calculated as 
nine months from data on packaging) and so a single contaminated 
batch could feasibly be responsible for this whole cluster. Prior to 
the recall in December 2018, newly purchased food had a declared 
shelf life to August 2019. This stored food and that in the freezers of 
owners who missed the recall may continue to extend the outbreak, 
albeit at a low level, for many months to come.
Overall, the authors believe that the most likely infection win-
dow was probably March to June 2018 and that all cases associated 
with this raw pet food could fit within this, with stored food and a 
protracted sub-clinical/latent phase giving rise to later cases. The 
estimate for a two- to five-month sub-clinical/latent period is sup-
ported by the currently observed decline in the presentation of new 
cases following the recall of the food in December 2018.
Other potential routes of infection were investigated and ex-
cluded. Transmission to the cats from the local environment was 
considered to be very unlikely because a) the cats were kept indoors, 
with only a few cats having limited, usually supervised, outdoor ac-
cess, and b) the majority of cases were located in areas of low bovine 
TB incidence. Infected vermin entering the houses cannot be ruled 
out for cases in only two households located in the HRA. However, 
they were not in regions with endemic M. bovis genotype 10:a infec-
tions in cattle.
Most owners of pedigree cats were located in the LRA and ob-
tained kittens from the LRA, but other cats in the same households 
had prior ownership which could not be fully investigated, so they 
could have had previous outdoor access in the HRA. Some of the 
non-pedigree cats had vague histories, including an in-contact cat 
that was obtained from a website with no history at all. Incomplete 
information creates some uncertainty for several of the cases and 
failure to confirm infection by the reference standard test for the 
majority of cases adds a degree of uncertainty as to the true number 
of M. bovis cases seen.
Within this group of 47 clinical cases, M. bovis genotype 10:a has 
been cultured from five cases from different areas of England and 
Scotland and all from out with the natural home range for this strain 
indicating that infection did not occur from local wildlife. To confirm 
the food as the source of these infections, a positive M. bovis 10:a 
culture from pet food obtained from owners could provide definitive 
evidence of the transmission route. However, batches matching the 
earlier period of the most likely infection window were, unsurpris-
ingly, no longer available at the time of diagnosis and M. bovis has not 
been isolated from the few later dated samples tested by APHA or 
the University of Edinburgh to date and this remains a weakness of 
this investigation.
4  | DISCUSSION
This cluster of cases represents a fully documented outbreak of 
feline tuberculosis putatively caused by feeding pet cats a con-
taminated commercial raw food diet. Previous examination of feline 
mycobacterial cases in the UK showed the highest frequency of in-
fections in non-pedigree male cats with frequently reported hunting 
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behaviour that then develop skin lesions, probably following inocula-
tion of mycobacteria directly into the site of the lesion (Gunn-Moore 
et al., 2011a; Gunn-Moore, 2014). By contrast, the majority of cases 
affected in this outbreak were pedigree or pedigree–cross-breeds 
(76.6%), most had abdominal disease (66.0%), and there was no sta-
tistically significant predilection for males to be affected. All cats 
were housed indoors with no reported history of hunting behav-
iour. The reason for the high proportion of pedigree cats affected 
is potentially that owners of these cats are more likely to feed raw 
food diets. Although this has not been studied systematically, an-
ecdotal evidence suggests that a growing number of pedigree cat 
breeders in the UK (and elsewhere) are advocating feeding “biologi-
cally appropriate raw food” (BARF) diets to owners acquiring kittens 
(Handl, 2014; Waters, 2017).
More than half of clinical cases in this outbreak presented 
with palpable abdominal masses (granulomas) and gastrointestinal 
lymphadenopathy supporting the hypothesis that this outbreak 
was due to contaminated food. In a study reporting the clinical 
presentation of feline mycobacterial infections in the UK out with 
this outbreak, the only alimentary-associated sign reported was 
weight loss, identified in 15.8% of cases, none of which had di-
rectly palpable masses (Gunn-Moore et al., 2011a). In the current 
cluster, twice the proportion of affected cats (31.9%) showed 
declining body weight and/or condition. Additionally, cats in this 
cluster were frequently anaemic and pyrexic which suggests that 
there may be a more severe phenotype of disease associated 
with this cluster than would be expected from sylvatic infections 
(which are rarely pyrexic; DGM data unpublished). This is also sup-
ported by the very high mortality rate reported for the early cases 
(O’Halloran et al., 2019). The reasons for this are not immediately 
clear; it may be that these cats were exposed to the largest amount 
of contamination, or it may be that these cats, being largely pedi-
gree breeds, responded differently to mycobacteria; for example, 
susceptibility to M. avium–intracellulare complex infection and dis-
ease has previously been reported in Abyssinian cats (Baral et al., 
2006). Alternatively, it may be that certain genotypes of M. bovis 
such as 10:a are particularly virulent in the context of compan-
ion animal infections; for example, when the same genotype in-
fected a group of Foxhounds it caused fatal fulminant infections 
in a number of animals (O’Halloran, Hope, et al., 2018). However, 
there have been insufficient numbers of cases to provide evidence 
to support this and further work is needed to investigate the host–
pathogen interaction of M. bovis strains and companion animals; it 
may be significant in predicting patient prognosis and qualifying 
zoonotic risk to owners.
Many of the cats were found to have unexpected respiratory 
changes. The presence of individual demarcated granulomas ap-
pears to be most consistent with primary inhalation of bacilli into 
the lungs, presumptively as these cats were eating contaminated 
food. In a number of cases, the pattern of lung pathology was more 
suggestive of disease spreading from a separate focus (such as the 
gastrointestinal tract). The interstitial lung pattern seen when im-
aging these latter cases indicates likely haematogenous spread of 
infection and influx of inflammatory cells into the lung parenchyma. 
Importantly, many of the IGRA-positive cats with no detectable re-
spiratory signs reported by owners or on clinical examination but 
were found to have thoracic pathology on imaging, highlighting the 
need for veterinary surgeons to investigate cases thoroughly if there 
are concerns over potential exposure.
The epidemiological investigation into this outbreak has demon-
strated that the most likely source of infection of these cats was 
the consumption of a specific brand of commercial raw food diet 
and that one contaminated batch or even a single contaminated 
deer carcass could potentially have been responsible for all of the 
cases diagnosed. In order to increase the certainty of these investi-
gations, it would have been beneficial to have had a greater number 
of samples submitted for the reference standard test of mycobacte-
rial culture, as genotyping and sequencing isolates adds significant 
clarity. However, this was hindered at the start of this outbreak by 
the lack of state funding for most companion animal samples so that 
the cost to owners for official confirmation of M. bovis infection 
through APHA is now estimated to be in excess of £500 (including 
post-mortem examination). Many owners saw this as prohibitive; 
however, there was significantly greater uptake of this option when 
the decision was taken by APHA to temporarily relax the eligibil-
ity criteria for funded submissions after the initial cases presented. 
As an alternative, owners chose to use non-validated but less costly 
tests; further work to validate these tests would be beneficial for the 
investigation of any future outbreaks.
Definitive proof that the implicated raw food was the source 
of infection in these cats would require the isolation of viable M. 
bovis organisms from a sample of the food from the at-risk period. 
However, five samples obtained from owner-retained food packages 
have been tested to date by culture and have been found to be neg-
ative. This may have been because the food samples submitted were 
from the time that the cats were diagnosed rather than the point at 
which they may have been infected. Additionally, the bulk purchasing 
of food by owners further creates problems for test sensitivity when 
large batches of food (several kilograms per household) need exam-
ining by culture or PCR. Long periods of freezing may also reduce 
the sensitivity of mycobacterial culture from samples (DEFRA, 2007).
Given the strong suspicions that these cats were infected by a 
commercial food product, this poses a critical question with respect 
to how the product became contaminated. Game animals such as 
deer from across the UK could be at risk of infection with M. bovis or 
a number of other diseases communicable to humans and animals. 
As the number of raw pet food products on sale in the UK and else-
where increases, it is critical that the safety of the meat products 
used to manufacture them is maintained. Under UK legislation, raw 
pet food can only be made from slaughterhouse material that was 
passed fit for humans to eat but is unwanted for commercial rea-
sons: fish by-products from factories and ships that prepare fish for 
human consumption; material from animals that passed an ante mor-
tem test but is unfit for humans to eat, for example liver with fluke; 
or from game that was passed fit for humans to eat but rejected for 
commercial reasons, not due to disease. The safety of game entering 
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the food chain is governed by The Wild Game Meat (Hygiene and 
Inspection) Regulations 1995 which sets out detailed requirements 
for carcass inspection and handling prior to the consumption of game 
meat. However, the Food Standards Agency (FSA) state in the recall 
of the cat food product implicated in this outbreak that it was be-
cause “the ingredients were not inspected in line with EU [European 
Union] requirements” (FSA, 2018). The inclusion of meat from insuf-
ficiently examined carcasses in a raw food product is extremely high 
risk for the spread of infectious diseases, including the potential for 
tuberculosis as we have previously documented in hunting hounds. 
It also exposes anyone working with or handling the product to the 
risk of disease, such as workers in cutting plants breaking down car-
casses with machinery that could easily generate transmissible aero-
sols of tuberculosis. One other possible route of contamination is 
that because the whole carcass of a large game animal is not always 
required for post-mortem inspection to certify it as fit for human con-
sumption, lesions may be missed. For example, for deer, the head 
can be discarded prior to inspection, even though a common loca-
tion for tuberculous lesions is the palatine tonsils (Waters & Palmer, 
2015). Because it is plausible that a single infected deer carcass led 
to the infection of at least 128 cats in this outbreak, the circum-
stances demonstrate the critical importance of meat inspection and 
the essential role of trained meat inspectors to this process for the 
protection of both human and animal health. Since IGRA was the 
only way to look for evidence of possible M. bovis infection in the 
cats with no clinical signs, the possibility of false-positive results in 
this group of cats cannot be excluded; however, the risk of missing a 
clinically infected cat was felt to outweigh the risk of false positives 
and as many test-positive cats were investigated further.
In conclusion, this study reports a large outbreak of M. bovis 
tuberculosis in pet cats where there was compelling evidence that 
a contaminated raw food product was the origin; 47 cats were 
found to have clinical tuberculosis, while another 83 in-contact 
cats were found to have positive IGRA responses consistent with 
MTBC infection but no active disease. Based on our estimates of 
the approximate time from infection to disease appearing and from 
the epidemiological investigation, it is possible that a single batch 
of contaminated food produced in late 2017 or early 2018 resulted 
in the whole cluster of cases. Four cat owners and one veterinary 
surgeon were diagnosed with suspected latent TB, potentially due 
to exposure to infected cats with purulent lesions and/or their con-
taminated feed, though this remains unproven and the risk posed by 
M. bovis-infected cats to humans is very low. This outbreak demon-
strates the critical nature of veterinary meat inspection to maintain 
food safety for human and animals and poses questions for further 
research in order to investigate the mechanism of infection and the 
feline immune response to M. bovis.
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